CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 49 enrolled
Drug / intervention
Vigileo Monitor +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00526331
NCT00526331Phase 4Completed

Randomized Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy

M.D. Anderson Cancer Center·interventional·Posted Sep 10, 2007·Updated Jan 16, 2012

In Brief

A Phase 4 clinical trial evaluating Vigileo Monitor and FloTrac Sensor for Esophageal Diseases and 8 related conditions. Completed, enrolled 49 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether the early identification and more precise intervention of operating room (OR) patient fluid administration optimization using arterial pressure-based cardiac output (APCO) yields comparable patient outcome as fluid administration optimization using a global standard care method.

Study Details

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 10, 2007
Enrollment StartAug 1, 2007
Primary CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 18.8 years ago

Interventions

Vigileo Monitordevice

Study Group = The monitor and routine vital sign measurements will be used to decide how much fluid to give during surgery; Control Group = Information from the monitor will be collected and compared to the information collected from participants in Study Group.

FloTrac Sensordevice

Device connected to the patient's arterial line and Vigileo monitor that measures fluid requirements during surgery.